Scientists frequently utilize lentiviruses to customize cells genetically. Nevertheless, they should conquer numerous obstacles when utilizing these infections in the lab or clinic. In this episode, Charlene Lancaster from The Scientists Creative Services Team talked with Filippo Rossignoli, instructor in neurosurgery at the Center for Stem Cell and Translational Immunotherapy at Brigham and Womens Hospital and Harvard Medical School, about using lentiviruses to engineer cell treatments and the fixing process he carried out to optimize viral production and infection.More on this topic: Viral Vector Platforms for Gene TherapyLabTalk is a scandal sheet podcast produced by The Scientists Creative Services Team, where we check out subjects at the leading edge of ingenious research. This months episode is sponsored by Mirus Bio.Speaker: Filippo Rossignoli, PhDInstructor in NeurosurgeryCenter for Stem Cell and Translational ImmunotherapyBrigham and Womens HospitalHarvard Medical SchoolFor over 25 years, Mirus Bio has originated the advancement of transfection reagents and proprietary innovations for nucleic acid shipment applications and is developing the future of science and medicine by establishing products that allow product developers within the cell and gene therapy space. As we approach a new age of attending to and conquering life-altering illness, they will continue to broaden their know-how and leadership in transfection to be important in the future of advanced therapies.Sponsored by
